Roland W. Herzog
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
412
Citations
17,071
Est. group size
—
Recurring co-author estimate
Active years
33
Publishing since 1994
This researcher works on gene therapy, focusing on using engineered viruses (such as adeno-associated viruses, or AAV) to deliver therapeutic genes for inherited diseases like hemophilia and Duchenne muscular dystrophy. A major theme is understanding and controlling the body's immune responses to these gene-delivery vectors, including strategies to induce immune tolerance and improve safety and effectiveness of treatment.
Publication activity has been consistently high over the past decade, averaging around 20+ papers per year, with some year-to-year fluctuation.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer
Molecular Therapy · 2026
- Symbolic Regression for Shared Expressions: Introducing Partial Parameter Sharing
arXiv (Cornell University) · 2026
- Symbolic Regression for Shared Expressions: Introducing Partial Parameter Sharing
arXiv (Cornell University) · 2026
- Two Models for Surface Segmentation using the Total Variation of the Normal Vector
Journal of Mathematical Imaging and Vision · 2026
- Engineering immune tolerance for AAV gene therapy: The Norse way
Molecular Therapy · 2026
- Deaths in gene therapy of Duchenne muscular dystrophy and other diseases: Underlying mechanisms and mitigating strategies
Molecular Therapy · 2026
- Shape Constraints in Symbolic Regression Using Penalized Least Squares
Communications in computer and information science · 2026
- Total Generalized Variation of the Normal Vector Field and Applications to Mesh Denoising
arXiv (Cornell University) · 2025
- Canine Model of Duchenne Muscular Dystrophy
Methods in molecular biology · 2025
- Preface
Mathematical Control and Related Fields · 2025
- Clinical advances in gene, cell, and RNA therapies
Molecular Therapy · 2025
- Datenassimilation und optimale Sensorplatzierung
2025
- Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Chemical Reviews · 2025
- Entropy Scaling of Viscosity IV─Application to 124 Industrially Important Fluids
Journal of Chemical & Engineering Data · 2025
- Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy
Human Gene Therapy · 2025
- Molecular Therapy×61
- Blood×21
- arXiv (Cornell University)×21
- Molecular Therapy — Methods & Clinical Development×14
- Frontiers in Immunology×7
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile